Sort   by:  
 Page size 
UnknownABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.
Not available
S-EPMC4239162 | biostudies-literature
TranscriptomicsInhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities, but not Inflammation and Injury in Mice
Abnormalities in hepatic lipid metabolism are believed to play a critical role in the etiology of nonalcoholic steatohepatitis (NASH). Monoacylglycerol acyltransferase (MGAT) enzymes convert monoacylglycerol to diacylglycerol, which is the penultimate step in one pathway for triacylglycerol (TAG) sy...
ORGANISM(S): Mus musculus 
2014-11-05 | E-GEOD-60349 | biostudies-arrayexpress
UnknownPhospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis.
Not available
S-EPMC5807072 | biostudies-literature
ProteomicsComparative proteomic analysis of exosomes derived from endothelial cells and Schwann cells
Exosomes derived from endothelial cells and Schwann cells have been employed as novel treatments of neurological diseases, including peripheral neuropathy. Exosomal cargo plays a critical role in mediating recipient cell function. In this study, we thus performed a comprehensive proteomic analysis o...
ORGANISM(S): Mus musculus (Mouse) 
2023-08-20 | PXD041547 | Pride
Proteomics Exosomes Endothelial cells Protein Schwann cells 
UnknownABCG1 regulates pulmonary surfactant metabolism in mice and men.
Not available
S-EPMC5408613 | biostudies-literature
UnknownA genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.
Not available
S-EPMC6414286 | biostudies-literature
UnknownWestern Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure.
Not available
S-EPMC6610000 | biostudies-literature
UnknownDNA methylation and childhood asthma in the inner city.
Not available
S-EPMC4494877 | biostudies-literature
UnknownA phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
Not available
S-EPMC5344293 | biostudies-literature
UnknownMRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.
Not available
S-EPMC10330304 | biostudies-literature
Sort   by:  
 Page size